Sysalkapc Syrup

Overview Sysalkapc Syrup

Sysalkapc Syrup utilizes magnesium citrate and potassium citrate as its primary active components. Potassium citrate's action centers on altering renal citrate processing, primarily impacting urinary citrate levels, not citrate filtration. This adjustment results in urine less prone to crystallization of stone-forming salts (calcium oxalate, calcium phosphate, and uric acid), further inhibiting spontaneous nucleation of calcium oxalate and calcium phosphate (brushite). Magnesium citrate concurrently suppresses calcium oxalate crystal formation within the urine. Sysalkapc Syrup is indicated for: maintaining electrolyte equilibrium, preventing and/or treating kidney stones, supporting optimal renal function, and preventing calcium oxalate nephrolithiasis. Physician supervision is required.